Literature DB >> 7228411

Specific and nonspecific immune factors in dental plaque fluid and saliva from young and old populations.

M F Cole, S D Hsu, B J Baum, W H Bowen, L I Sierra, M Aquirre, G Gillespie.   

Abstract

Separate samples of supragingival dental plaque overtly free of blood were centrifuged to obtain the free fluid phase (plaque fluid). Bound protein was eluted from the plaque bacteria and matrix by washing the plaque with a low-pH buffer. The plaque fluid, low pH eluate, and whole saliva were assayed for immunoglobulins A, G, and M, the third component of complement, lysozyme, lactoferrin, and lactoperoxidase. Concentrations of total protein and albumin were also determined. Antibody reactive with specific plaque bacteria was detected by indirect immunofluorescent microscopy. Specific and nonspecific immune proteins were present in plaque fluid from adult subjects at significantly greater concentrations than in their saliva, which suggests that these proteins are concentrated in dental plaque. The results indicate that both saliva and gingival exudate contribute to the immunological proteins found in the free fluid phase of dental plaque. The observation that immunoglobulin A antibody reactive with plaque bacteria could be detected in plaque fluid suggests that a wide variety of immunological reactions may occur in the dental plaque. These potential interactions between host, plaque bacteria, and their products could serve to influence the plaque flora and its ability to induce disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7228411      PMCID: PMC351417          DOI: 10.1128/iai.31.3.998-1002.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  The microbiology and biochemistry of plaque, saliva, and drinking water from two communities with contrasting levels of caries in Colombia, S.A.

Authors:  W H Bowen; H Velez; M Aguila; H Velasquez; L I Sierra; G Gillespie
Journal:  J Dent Res       Date:  1977-10       Impact factor: 6.116

2.  Enzyme activity of salivary lactoperoxidase adsorbed to human enamel.

Authors:  K M Pruitt; M Adamson
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

3.  Antibacterial activity of lactoperoxidase adsorbed by human salivary sediment and hydroxyapatite.

Authors:  J Tenovuo; J Valtakoski; M L Knuuttila
Journal:  Caries Res       Date:  1977       Impact factor: 4.056

4.  Immune dysfunction and dental caries: a preliminary report.

Authors:  M F Cole; R R Arnold; M J Rhodes; J R McGhee
Journal:  J Dent Res       Date:  1977-03       Impact factor: 6.116

5.  Antibacterial effect of salivary peroxidases on a cariogenic strain of Streptococcus mutans.

Authors:  J Tenovuo; M L Knuuttila
Journal:  J Dent Res       Date:  1977-12       Impact factor: 6.116

6.  Measurement of salivary lysozyme.

Authors:  G Virella; J Goudswaard
Journal:  J Dent Res       Date:  1978-02       Impact factor: 6.116

Review 7.  The salivary secretions in health and disease.

Authors:  I D Mandel; S Wotman
Journal:  Oral Sci Rev       Date:  1976

8.  Coating of subgingival bacteria with immunoglobulin and complement.

Authors:  R Nisengard; C Jarrett
Journal:  J Periodontol       Date:  1976-09       Impact factor: 6.993

9.  The use of the o-phthalaldehyde reaction as a sensitive assay for protein and to determine protein in bacterial cells and dental plaque.

Authors:  S A Robrish; C Kemp; W H Bowen
Journal:  Anal Biochem       Date:  1978-01       Impact factor: 3.365

10.  Gingival fluid and serum in periodontal diseases. I. Quantitative study of immunoglobulins, complement components, and other plasma proteins.

Authors:  H A Schenkein; R J Genco
Journal:  J Periodontol       Date:  1977-12       Impact factor: 6.993

View more
  18 in total

1.  Antibacterial effect of lactoperoxidase and myeloperoxidase against Bacillus cereus.

Authors:  J Tenovuo; K K Mäkinen; G Sievers
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

2.  Prevalence, distribution of serotypes, and cariogenic potential in hamsters of mutans streptococci from elderly individuals.

Authors:  D B Fitzgerald; R J Fitzgerald; B O Adams; R E Morhart
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

3.  Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort.

Authors:  Y H Samaranayake; L P Samaranayake; E H Pow; V T Beena; K W Yeung
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

4.  Structural integrity of host defense factors in dental plaque.

Authors:  S D Hsu; M F Cole
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

5.  Effect of peroral immunization of humans with Streptococcus mutans on induction of salivary and serum antibodies and inhibition of experimental infection.

Authors:  M F Cole; C G Emilson; S D Hsu; S H Li; W H Bowen
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

6.  Factors influencing measurement of human salivary lysozyme in lysoplate and turbidimetric assays.

Authors:  J W Jenzano; S L Hogan; R L Lundblad
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

7.  Adherence of Streptococcus sanguis to hydroxyapatite coated with lysozyme and lysozyme-supplemented saliva.

Authors:  L M Tellefson; G R Germaine
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

8.  Antimicrobial factors in whole saliva of human infants.

Authors:  J Tenovuo; O P Lehtonen; A S Aaltonen; P Vilja; P Tuohimaa
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

9.  Killing of Actinobacillus actinomycetemcomitans by human lactoferrin.

Authors:  J R Kalmar; R R Arnold
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

10.  Effect of lysozyme on glucose fermentation, cytoplasmic pH, and intracellular potassium concentrations in Streptococcus mutans 10449.

Authors:  Y B Wang; G R Germaine
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.